Bleeding diathesis

Jump to: navigation, search


Bleeding diathesis main page

Overview

Classification

000
000
000

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2]

Overview

Classification

Differential Diagnosis

History Clinical manifestation Laboratory testing
Petechiae Ecchymoses Menorrhagia Hematomas Hemarthrosis platelet count Bleeding time (BT) Prothrombin time (PT) Platelet count activated partial thromboplastin time (aPTT) Thrombin time (TT)
Platelet disorders Thrombocytopenia Infection-Induced Thrombocytopenia
Drug-Induced Thrombocytopenia
Heparin-Induced Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Inherited Thrombocytopenia
Thrombotic Thrombocytopenic Purpura (TTP)
Hemolytic Uremic Syndrome
Thromobcytosis Thrombocytosis in response to acute or chronic inflammation has not been associated with an increased thrombotic risk. In fact, patients with markedly elevated platelet counts (>1.5 million), usually seen in the setting of a myeloproliferative disorder, have an increased risk of bleeding. This appears to be due, at least in part, to acquired von Willebrand disease (VWD) due to platelet-VWF adhesion and removal.
Qualitative Disorders of Platelet Function Inherited Disorders of Platelet Function
Acquired Disorders of Platelet Function
von Willebrand Disease Type 1
Type 2 A
Type 2 B
Type 2 M
Type 3
Vessel wall disorders Metabolic and Inflammatory Disorders
Inherited Disorders of the Vessel Wall
Coagulation disorders Fibrinogen deficiency
Prothrombin deficiency
Factor V deficiency
Factor VII deficiency
Factor VIII deficiency
Factor IX deficiency
Factor X deficiency
Factor XI deficiency
Factor XII deficiency
HK deficiency
Prekallikrein deficiency
Factor XIII deficiency
Hemophilia Type A deficiency
Type B deficiency
Type C deficiency
Rare diseases Disseminated Intravascular Coagulation
Vitamin K Deficiency
Coagulation Disorders Associated with Liver Failure
Acquired Inhibitors of Coagulation Factors

Linked-in.jpg